Key Sessions
Aurélie Goyenvalle
Addressing Novel Delivery Tools Needed to Support Next-Gen RNA Therapeutics
INSERM
Tomas Kostelec
Advancing mRNA therapeutics with better control over mRNA manufacturing yield, quality, and formulation
Sartorius
Alexander Zehnder
CEO Insights - Accelerating Innovation and Commercialisation of RNA Therapeutics and Vaccines
CureVac
John Taylor
RNA Partnerships of Big Pharma, Biotech, Industry Providers
Ribocure
Paola Pozzi
Investment in Nucleic Acid Therapeutics and Enabling Technologies
Sofinnova Partners